Patents by Inventor Song Young Kim

Song Young Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Conductive structure, manufacturing method therefor, and electrode comprising conductive structure
    Patent number: 11926558
    Abstract: The present specification relates to a conductive structure body, a method for manufacturing the same, and an electrode and an electronic device including the conductive structure body.
    Type: Grant
    Filed: March 28, 2016
    Date of Patent: March 12, 2024
    Assignee: LG CHEM LTD.
    Inventors: Ilha Lee, Seung Heon Lee, Song Ho Jang, Dong Hyun Oh, Ji Young Hwang, Ki-Hwan Kim, Han Min Seo, Chan Hyoung Park, Sun Young Park
  • Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
    Patent number: 9068019
    Abstract: The present invention relates to a modified human tumor necrosis factor receptor-1 polypeptide to be coupled to a tumor necrosis factor in vivo or ex vivo, or to a fragment thereof. The modified human tumor necrosis factor receptor-1 polypeptide or the fragment thereof according to the present invention exhibit improved resistance against in vivo protease activity, and thus exhibit improved bioavailability and an improved absorption rate.
    Type: Grant
    Filed: October 19, 2010
    Date of Patent: June 30, 2015
    Assignee: HANALL BIOPHARMA CO., LTD.
    Inventors: Sung Wuk Kim, Sung Soo Jun, Seung Kook Park, Song Young Kim, Eun Sun Kim, Jae Kap Jeong, Ha Na Kim, Yeon Jung Song
  • Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing same
    Patent number: 8895500
    Abstract: The present invention relates to a modified human tumor necrosis factor receptor-1 polypeptide which is capable of binding to a tumor necrosis factor in vivo or ex vivo, or to a fragment thereof. The modified human tumor necrosis factor receptor-1 polypeptide or the fragment thereof according to the present invention exhibit improved binding affinity to the tumor necrosis factor.
    Type: Grant
    Filed: September 7, 2011
    Date of Patent: November 25, 2014
    Assignee: Hanall Biopharma Co., Ltd.
    Inventors: Sung Wuk Kim, Sung Soo Jun, Seung Kook Park, Song Young Kim, Eun Sun Kim, Jae Kap Jeong, Ha Na Kim, Yeon Jung Song
  • Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
    Patent number: 8754037
    Abstract: Provided is a modified human tumor necrosis factor receptor-1 polypeptide or a fragment thereof that binds to a tumor necrosis factor in vivo or ex vivo. The modified human tumor necrosis factor receptor-1 polypeptide or fragment exhibits improved ability to bind tumor necrosis factor and resistance to proteases.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: June 17, 2014
    Assignee: Hanall Biopharma Co., Ltd.
    Inventors: Sung Wuk Kim, Sung Soo Jun, Seung Kook Park, Song Young Kim, Eun Sun Kim, Jae Kap Jeong, Ha Na Kim, Yeon Jung Song
  • Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
    Patent number: 8618045
    Abstract: Provided is a modified human tumor necrosis factor receptor-1 polypeptide or a fragment thereof that binds to a tumor necrosis factor in vivo or ex vivo. The modified human tumor necrosis factor receptor-1 polypeptide or fragment exhibits improved ability to bind tumor necrosis factor and resistance to proteases.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: December 31, 2013
    Assignee: Hanall Biopharma Co., Ltd.
    Inventors: Sung Wuk Kim, Sung Soo Jun, Seung Kook Park, Song Young Kim, Eun Sun Kim, Jae Kap Jeong, Ha Na Kim, Yeon Jung Song
  • MODIFIED HUMAN TUMOR NECROSIS FACTOR RECEPTOR-I POLYPEPTIDE OR FRAGMENT THEREOF, AND METHOD FOR PREPARING SAME
    Publication number: 20130237472
    Abstract: The present invention relates to a modified human tumor necrosis factor receptor-1 polypeptide which is capable of binding to a tumor necrosis factor in vivo or ex vivo, or to a fragment thereof.
    Type: Application
    Filed: September 7, 2011
    Publication date: September 12, 2013
    Applicant: HANALL BIOPHARMA CO., LTD.
    Inventors: Sung Wuk Kim, Sung Soo Jun, Seung Kook Park, Song Young Kim, Eun Sun Kim, Jae Kap Jeong, Ha Na Kim, Yeon Jung Song
  • MODIFIED HUMAN TUMOR NECROSIS FACTOR RECEPTOR-1 POLYPEPTIDE OR FRAGMENT THEREOF, AND METHOD FOR PREPARING SAME
    Publication number: 20120277142
    Abstract: Provided is a modified human tumor necrosis factor receptor-1 polypeptide or a fragment thereof that binds to a tumor necrosis factor in vivo or ex vivo. The modified human tumor necrosis factor receptor-1 polypeptide or fragment exhibits improved ability to bind tumor necrosis factor and resistance to proteases.
    Type: Application
    Filed: December 21, 2011
    Publication date: November 1, 2012
    Applicant: HANALL BIOPHARMA CO., LTD.
    Inventors: Sung Wuk Kim, Sung Soo Jun, Seung Kook Park, Song Young Kim, Eun Sun Kim, Jae Kap Jeong, Ha Na Kim, Yeon Jung Song
  • MODIFIED HUMAN TUMOR NECROSIS FACTOR RECEPTOR-1 POLYPEPTIDE OR FRAGMENT THEREOF, AND METHOD FOR PREPARING SAME
    Publication number: 20120251486
    Abstract: The present invention relates to a modified human tumor necrosis factor receptor-1 polypeptide to be coupled to a tumor necrosis factor in vivo or ex vivo, or to a fragment thereof. The modified human tumor necrosis factor receptor-1 polypeptide or the fragment thereof according to the present invention exhibit improved resistance against in vivo protease activity, and thus exhibit improved bioavailability and an improved absorption rate.
    Type: Application
    Filed: October 19, 2010
    Publication date: October 4, 2012
    Applicant: HANALL BIOPHARMA CO., LTD.
    Inventors: Sung Wuk Kim, Sung Soo Jun, Seung Kook Park, Song Young Kim, Eun Sun Kim, Jae Kap Jeong, Ha Na Kim, Yeon Jung Song
  • Preparation method for the production of active and soluble proteins in prokaryotes and polycistronic vectors therefor
    Patent number: 7811786
    Abstract: Disclosed are a method of producing a target protein in a biologically-active, soluble form in prokaryotic cells and polycistronic vectors therefor.
    Type: Grant
    Filed: June 11, 2004
    Date of Patent: October 12, 2010
    Assignee: Daewoong Co., Ltd.
    Inventors: Bong Yong Lee, Seung Kook Park, Shin Hye Park, Oh Byung Kwon, Chae Ha Yoon, Young Ju Kim, Song Young Kim, Kyung Hyun Min, Yoon Seok Lee, Tae Hee Lee, Tai Young Koo